RNA was extracted from control and drug-treated cells using TRIzol as specified by the manufacturer's protocol. The RNA was treated with DNase (DNase I-RNase-Free; Ambion; Thermo Fisher Scientific, Inc.) to remove any contaminating DNA; 200 ng of total RNA was reverse-transcribed with oligo dT primers using the SuperScript
™ III RT-PCR kit (Applied Biosystems; Thermo Fisher Scientific, Inc.) in a 20 µl reaction, as specified by the manufacturer's protocol. For quantitative PCR, the template cDNA was added to a 20 µl reaction with
Power SYBR-Green PCR Master mix and 0.2 µM of primers for the target genes and GAPDH.
The primer sequences were as follows: LC3A forwards, GCC TTT CAA GCA GCG GCG GAG C, and reverse, TTG GTC TTG TCC AGG ACG GGC A; LC3B forwards, CAG CGT CTC CAC ACC AAT CTC A, and reverse, AAT TTC ATC CCG AAC GTC TCC T; Beclin-1 forwards, CTC CAT TAC TTA CCA CAG CCC A, and reverse, GGA TGA ATC TGC GAG AGA CAC C; GAPDH forwards, GCA AAT TCC ATG GCA CCG T, and reverse, TCG CCC CAC TTG ATT TTG G.
Amplification was performed with a Prism 7000 machine (Applied Biosystems; Thermo Fisher Scientific, Inc.), with the following conditions: Initial denaturation at 95°C for 10 min, then 40 cycles of 95°C for 15 sec followed by 60°C for 1 min. The fold changes relative to GAPDH were calculated using the 2
−∆∆Cq method (17 (
link)).
Wang Y., Gao H., Wu T., Wang Z., Song F., Chen A., Zhang J., Zhang W., Zhang H, & Yu J. (2017). Pseudolaric acid B induced autophagy, but not apoptosis, in MRC5 human fibroblast cells. Oncology Letters, 15(1), 863-870.